482 related articles for article (PubMed ID: 30674630)
1. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
Yu J; Liang C; Liu SL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
[TBL] [Abstract][Full Text] [Related]
2. Interferon-inducible LY6E Protein Promotes HIV-1 Infection.
Yu J; Liang C; Liu SL
J Biol Chem; 2017 Mar; 292(11):4674-4685. PubMed ID: 28130445
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic Correlates of HIV-1 Macrophage Tropism.
Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpu Promotes Phagocytosis of Infected CD4
Cong L; Sugden SM; Leclair P; Lim CJ; Pham TNQ; Cohen ÉA
mBio; 2021 Aug; 12(4):e0192021. PubMed ID: 34425695
[TBL] [Abstract][Full Text] [Related]
5. IFN-stimulated gene LY6E in monocytes regulates the CD14/TLR4 pathway but inadequately restrains the hyperactivation of monocytes during chronic HIV-1 infection.
Xu X; Qiu C; Zhu L; Huang J; Li L; Fu W; Zhang L; Wei J; Wang Y; Geng Y; Zhang X; Qiao W; Xu J
J Immunol; 2014 Oct; 193(8):4125-36. PubMed ID: 25225669
[TBL] [Abstract][Full Text] [Related]
6. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
[TBL] [Abstract][Full Text] [Related]
7. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
Yu J; Liu SL
Viruses; 2018 Aug; 10(8):. PubMed ID: 30087232
[TBL] [Abstract][Full Text] [Related]
8. Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication.
Argañaraz ER; Schindler M; Kirchhoff F; Cortes MJ; Lama J
J Biol Chem; 2003 Sep; 278(36):33912-9. PubMed ID: 12816953
[TBL] [Abstract][Full Text] [Related]
9. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.
Joseph SB; Arrildt KT; Swanstrom AE; Schnell G; Lee B; Hoxie JA; Swanstrom R
J Virol; 2014 Feb; 88(4):1858-69. PubMed ID: 24307580
[TBL] [Abstract][Full Text] [Related]
10. Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.
Li H; Zony C; Chen P; Chen BK
J Virol; 2017 May; 91(9):. PubMed ID: 28148796
[TBL] [Abstract][Full Text] [Related]
11. LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step.
Mar KB; Rinkenberger NR; Boys IN; Eitson JL; McDougal MB; Richardson RB; Schoggins JW
Nat Commun; 2018 Sep; 9(1):3603. PubMed ID: 30190477
[TBL] [Abstract][Full Text] [Related]
12. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
Misra A; Gleeson E; Wang W; Ye C; Zhou P; Kimata JT
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321330
[TBL] [Abstract][Full Text] [Related]
13. CD4 Expression and Env Conformation Are Critical for HIV-1 Restriction by SERINC5.
Zhang X; Shi J; Qiu X; Chai Q; Frabutt DA; Schwartz RC; Zheng YH
J Virol; 2019 Jul; 93(14):. PubMed ID: 31043528
[TBL] [Abstract][Full Text] [Related]
14. Trehalose Inhibits Human Immunodeficiency Virus Type 1 Infection in Primary Human Macrophages and CD4
Rawat P; Hon S; Teodorof-Diedrich C; Spector SA
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554696
[TBL] [Abstract][Full Text] [Related]
15. A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Tang X; Jin H; Chen Y; Li L; Zhu Y; Chong H; He Y
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462566
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 requires Arf6-mediated membrane dynamics to efficiently enter and infect T lymphocytes.
García-Expósito L; Barroso-González J; Puigdomènech I; Machado JD; Blanco J; Valenzuela-Fernández A
Mol Biol Cell; 2011 Apr; 22(8):1148-66. PubMed ID: 21346189
[TBL] [Abstract][Full Text] [Related]
18. Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages.
Zheng N; Fujiwara M; Ueno T; Oka S; Takiguchi M
J Virol; 2009 Aug; 83(15):7668-77. PubMed ID: 19457989
[TBL] [Abstract][Full Text] [Related]
19. CD4
Zhang G; Campbell GR; Zhang Q; Maule E; Hanna J; Gao W; Zhang L; Spector SA
mBio; 2020 Sep; 11(5):. PubMed ID: 32934078
[TBL] [Abstract][Full Text] [Related]
20. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
Ly A; Stamatatos L
J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
